CIBBIM - Nanomedicine

Functional Validation & Preclinical Research (FVPR)

Ibane Abasolo Olaortua

Summary

FVPR is a technological platform able to perform, with a scientific, technological and regulatory perspective, a complete preclinical validation of a drug candidate or nanomedicine. Furthermore, FVPR also directly leads competitive research projects, in which we deepen in the use and translation of nanomedicines for treating cancer and lysosomal storage disorders.

As for the most relevant achievements of 2015, FVPR has published works related to internal projects (Fernández et al and Gener et al) as well as those developed in collaboration with biotech companies (Rocas et al.) and research groups (Romero-Hernandez et al., Rodriguez-Carmona et al., etc.). Non-competitive incomes in 2015 (222.000 €) came from collaborative projects with the industry (4 companies), groups within VHIR (10) and additional national and international research institutions (4).

Publications

2

total

4^.872

impact factor

4^.872

average impact factor

Main research projects